Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02922036 · ClinicalTrials.gov registry record · NA
Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients
A NA study of Heart Failure, sponsored by EBR Systems.
- Active
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 20
- Study locations
NCT02922036: Active NA study of Heart Failure, sponsored by EBR Systems.
NCT02922036 is a NA study of Heart Failure that is active but no longer recruiting, run by EBR Systems. The registered enrollment target is 300 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (85% lower). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02922036, a NA study of Heart Failure, is active but no longer recruiting, sponsored by EBR Systems.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study is a prospective, multi-center, pivotal trial to study the safety and efficacy of the WiSE-CRT System for Cardiac Re-synchronization Therapy.
Primary Outcome
Freedom from Procedure and Device System related Type 1 Complications
Conditions Studied
Interventions
- DEVICE WiSE System
Study Locations (20)
Florida
- Broward Health Medical Center - Fort Lauderdale
- St. Vincent's Healthcare - Jacksonville
- Watson Clinic - Lakeland
- Naples Community Hospital - Naples
- Northside Hospital and Heart Institute - St. Petersburg
Michigan
- University of Michigan - Ann Arbor
- Michigan Heart - Canton
- Henry Ford Hospital - Detroit
- William Beaumont Hospital - Hazel Park
Georgia
- Piedmont Heart Institute - Atlanta
- Emory Healthcare - Atlanta
Kansas
- Saint Luke's Health System Kansas City - Kansas City
- The University of Kansas Medical Center - Kansas City
Alabama
- Heart Center Research - Huntsville
California
- University of California, San Diego - La Jolla
Illinois
- Prairie Heart - Springfield
Indiana
- St. Vincent's Hospital and Healthcare Center - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2018-01-17 |
| Est. Completion | 2026-06 |
| Phase | NA |
What the registry record for NCT02922036 still lists
NCT02922036 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which WiSE System is the first listed.
NCT02922036 names 20 study sites across 11 states, led by Florida, Michigan, Georgia.
Frequently Asked Questions
What is clinical trial NCT02922036 about?
NCT02922036 is a clinical study titled "Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients". This study is a prospective, multi-center, pivotal trial to study the safety and efficacy of the WiSE-CRT System for Cardiac Re-synchronization Therapy.
What is the current status of trial NCT02922036?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2018-01-17. Estimated completion is 2026-06.
What conditions does trial NCT02922036 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT02922036?
The interventions under investigation include: WiSE System (DEVICE).
Who is sponsoring clinical trial NCT02922036?
This trial is sponsored by EBR Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02922036 being conducted?
This trial has 20 study locations across Alabama, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02922036's enrollment target sits among peer trials
300 138th of 397 higher than 253 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI